Drospirenone Patent Expiration
Drospirenone is Used for preventing pregnancy in females of reproductive age. It was first introduced by Exeltis Usa Inc
Drospirenone Patents
Given below is the list of patents protecting Drospirenone, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Drospirenone | US10179140 | Pharmaceutical compositions comprising active drugs, contraceptive kits comprising active drugs, and methods of administering the same | Jun 28, 2031 | Exeltis Usa Inc |
| Drospirenone | US10603281 | Pharmaceutical compositions comprising active drugs, contraceptive kits comprising active drugs, and methods of administering the same | Jun 28, 2031 | Exeltis Usa Inc |
| Drospirenone | US10849857 | Pharmaceutical compositions comprising active drugs, contraceptive kits comprising active drugs, and methods of administering the same | Jun 28, 2031 | Exeltis Usa Inc |
| Drospirenone | US10987364 | Synthetic progestogens and pharmaceutical compositions comprising the same | Jun 28, 2031 | Exeltis Usa Inc |
| Drospirenone | US11123299 | Synthetic progestogens and pharmaceutical compositions comprising the same | Jun 28, 2031 | Exeltis Usa Inc |
| Drospirenone | US11291632 | Synthetic progestogens and pharmaceutical compositions comprising the same | Jun 28, 2031 | Exeltis Usa Inc |
| Drospirenone | US11291633 | Synthetic progestogens and pharmaceutical compositions comprising the same | Jun 28, 2031 | Exeltis Usa Inc |
| Drospirenone | US11351122 | Synthetic progestogens and pharmaceutical compositions comprising the same | Jun 28, 2031 | Exeltis Usa Inc |
| Drospirenone | US11413249 | Synthetic progestogens and pharmaceutical compositions comprising the same | Jun 28, 2031 | Exeltis Usa Inc |
| Drospirenone | US11439598 | Synthetic progestogens and pharmaceutical compositions comprising the same | Jun 28, 2031 | Exeltis Usa Inc |
| Drospirenone | US11478487 | Synthetic progestogens and pharmaceutical compositions comprising the same | Jun 28, 2031 | Exeltis Usa Inc |
| Drospirenone | US11504334 | Synthetic progestogens and pharmaceutical compositions comprising the same | Jun 28, 2031 | Exeltis Usa Inc |
| Drospirenone | US11951213 | Synthetic progestogens and pharmaceutical compositions comprising the same | Jun 28, 2031 | Exeltis Usa Inc |
| Drospirenone | US12090231 | Synthetic progestogens and pharmaceutical compositions comprising the same | Jun 28, 2031 | Exeltis Usa Inc |
| Drospirenone | US9603860 | Pharmaceutical compositions comprising active drugs, contraceptive kits comprising active drugs, and methods of administering the same | Jun 28, 2031 | Exeltis Usa Inc |
| Slynd | US10179140 | Pharmaceutical compositions comprising active drugs, contraceptive kits comprising active drugs, and methods of administering the same | Jun 28, 2031 | Exeltis Usa Inc |
| Slynd | US10603281 | Pharmaceutical compositions comprising active drugs, contraceptive kits comprising active drugs, and methods of administering the same | Jun 28, 2031 | Exeltis Usa Inc |
| Slynd | US10849857 | Pharmaceutical compositions comprising active drugs, contraceptive kits comprising active drugs, and methods of administering the same | Jun 28, 2031 | Exeltis Usa Inc |
| Slynd | US10987364 | Synthetic progestogens and pharmaceutical compositions comprising the same | Jun 28, 2031 | Exeltis Usa Inc |
| Slynd | US11123299 | Synthetic progestogens and pharmaceutical compositions comprising the same | Jun 28, 2031 | Exeltis Usa Inc |
| Slynd | US11291632 | Synthetic progestogens and pharmaceutical compositions comprising the same | Jun 28, 2031 | Exeltis Usa Inc |
| Slynd | US11291633 | Synthetic progestogens and pharmaceutical compositions comprising the same | Jun 28, 2031 | Exeltis Usa Inc |
| Slynd | US11351122 | Synthetic progestogens and pharmaceutical compositions comprising the same | Jun 28, 2031 | Exeltis Usa Inc |
| Slynd | US11413249 | Synthetic progestogens and pharmaceutical compositions comprising the same | Jun 28, 2031 | Exeltis Usa Inc |
| Slynd | US11439598 | Synthetic progestogens and pharmaceutical compositions comprising the same | Jun 28, 2031 | Exeltis Usa Inc |
| Slynd | US11478487 | Synthetic progestogens and pharmaceutical compositions comprising the same | Jun 28, 2031 | Exeltis Usa Inc |
| Slynd | US11504334 | Synthetic progestogens and pharmaceutical compositions comprising the same | Jun 28, 2031 | Exeltis Usa Inc |
| Slynd | US11951213 | Synthetic progestogens and pharmaceutical compositions comprising the same | Jun 28, 2031 | Exeltis Usa Inc |
| Slynd | US12090231 | Synthetic progestogens and pharmaceutical compositions comprising the same | Jun 28, 2031 | Exeltis Usa Inc |
| Slynd | US9603860 | Pharmaceutical compositions comprising active drugs, contraceptive kits comprising active drugs, and methods of administering the same | Jun 28, 2031 | Exeltis Usa Inc |
A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Drospirenone's patents.
Latest Legal Activities on Drospirenone's Patents
Given below is the list recent legal activities going on the following patents of Drospirenone.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 4th Year, Large Entity | 03 Jun, 2024 | US10849857 |
| Patent Issue Date Used in PTA Calculation Critical | 09 Apr, 2024 | US11951213 |
| Email Notification Critical | 09 Apr, 2024 | US11951213 |
| Recordation of Patent eGrant | 09 Apr, 2024 | US11951213 |
| Patent eGrant Notification | 09 Apr, 2024 | US11951213 |
| Mail Patent eGrant Notification | 09 Apr, 2024 | US11951213 |
| Recordation of Patent Grant Mailed Critical | 09 Apr, 2024 | US11951213 |
| Email Notification Critical | 21 Mar, 2024 | US11951213 |
| Issue Notification Mailed Critical | 20 Mar, 2024 | US11951213 |
| Dispatch to FDC | 01 Mar, 2024 | US11951213 |
Drospirenone's Family Patents
Explore Our Curated Drug Screens
Drospirenone Generic API Manufacturers
Only one generic application has been filed for Drospirenone.
Given below is the list of companies who have filed for Drospirenone generic, along with the locations of their manufacturing plants worldwide.
1. LUPIN LTD
Lupin Ltd has filed for 1 generic for Drospirenone. Given below are the details of the strengths of this generic introduced by Lupin Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 4MG | tablet | Prescription | ORAL | AB | Sep 30, 2024 |
Manufacturing Plant Locations New
Lupin Ltd's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Lupin Ltd as present at those locations.
| Country | City | Firm Name | ||
|---|---|---|---|---|
| India |
| |||